Blood glucose may be an alternative to cholesterol in CVD risk prediction charts

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Braun, Julia ^a   Bopp, Matthias ^a   Faeh, David ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Blood cholesterol; Blood glucose; Cardiovascular disease mortality; Risk prediction; Risk score

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SELF REPORT; SENSITIVITY ANALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESIDENCE CHARACTERISTICS; RISK FACTORS; SWITZERLAND;

EID: 84872787803     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-24     Document Type: Article

References (33)

1. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24(11):987-1003. 10.1016/S0195-668X(03)00114-3, 12788299.
2. Gutzwiller F, Nater B, Martin J. Community-based primary prevention of cardiovascular disease in Switzerland: methods and results of the National Research Program (NRP 1A). Prev Med 1985, 14(4):482-491. 10.1016/0091-7435(85)90008-8, 4070186.
3. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011, 19(1):CD004816.
4. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006, 368(9548):1651-1659. 10.1016/S0140-6736(06)69700-6, 17098083.
5. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. Bmj 2009, 338:b605. 10.1136/bmj.b605, 19477892.
6. OECD Health at a Glance: Europe 2012 2012, OECD Publishing, http://ec.europa.eu/health/reports/docs/health_glance_en.pdf. Accessed 2013 Feb 26, OECD.
7. Swiss Federal Statistical Office 2012, Available: http://www.bfs.admin.ch/bfs/portal/de/index/infothek/erhebungen__quellen.html. Accessed 2013 Jan 11.
8. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011, 377:578-586. 10.1016/S0140-6736(10)62038-7, 21295847.
9. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567. 10.1016/S0140-6736(10)62037-5, 21295846.
10. Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrlander C, Rougemont A. Egger M: Cohort Profile: the Swiss National Cohort--a longitudinal study of 6.8 million people. Int J Epidemiol 2009, 38(2):379-384.
11. Bopp M, Braun J, Gutzwiller F, Faeh D. Health Risk or Resource? Gradual and Independent Association between Self-Rated Health and Mortality Persists Over 30 Years. PLoS One 2012, 7(2):e30795. 10.1371/journal.pone.0030795, 3276505, 22347405.
12. Gneiting T, Raftery AE. Strictly proper scoring rules, prediction and estimation. Journal of the American Statistical Association 2007, 102:359-378.
13. Ludbrook J, Dudley H. Why permutation tests are superior to t and F tests in biomedical research 52. American Statistician 1998, 52(2):127-132.
14. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. discussion 207-112, 10.1002/sim.2929, 17569110.
15. National Center for Health Statistics Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 1994, 32:1-407. National Center for Health Statistics.
16. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002, 105(3):310-315. 10.1161/hc0302.102575, 11804985.
17. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Jama 2001, 286(2):180-187. 10.1001/jama.286.2.180, 11448281.
18. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375(9733):2215-2222. 10.1016/S0140-6736(10)60484-9, 2904878, 20609967.
19. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364(9):829-841.
20. Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol 2011, 10:102. 10.1186/1475-2840-10-102, 3286386, 22104275.
21. Verhagen SN, Wassink AM, van der Graaf Y, Gorter PM, Visseren FL. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovasc Diabetol 2011, 10:100. 10.1186/1475-2840-10-100, 3268731, 22098712.
22. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005, 142(8):611-619. 2505046, 15838067.
23. Kendall D, Vail A, Amin R, Barrett T, Dimitri P, Ivison F, Kibirige M, Mathew V, Matyka K, McGovern A. Metformin in Obese Children and Adolescents: The MOCA Trial. J Clin Endocrinol Metab 2013, 98(1):322-329. http://www.ncbi.nlm.nih.gov/pubmed/23175691, 10.1210/jc.2012-2710, 23175691.
24. Iqbal N, Rubenstein AH. Does lowering of blood glucose improve cardiovascular morbidity and mortality?. Clin J Am Soc Nephrol 2008, 3(1):163-167. 10.2215/CJN.05041107, 18178783.
25. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374(9702):1677-1686. 10.1016/S0140-6736(09)61457-4, 3135022, 19878986.
26. Lily M, Godwin M. Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician 2009, 55(4):363-369. 2669003, 19366942.
27. Abikshyeet P, Ramesh V, Oza N. Glucose estimation in the salivary secretion of diabetes mellitus patients. Diabetes Metab Syndr Obes 2012, 5:149-154. 3422906, 22923999.
28. Bundesamt für Statistik Gesundheit und Gesundheitsverhalten in der Schweiz 2007 2010, Neuchâtel: Schweizerische Gesundheitsbefragung, Bundesamt für Statistik.
29. Faeh D, Braun J, Tarnutzer S, Bopp M. Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country. Eur J Prev Cardiol 2013, 20(1):151-160. http://www.ncbi.nlm.nih.gov/pubmed/22080525, 10.1177/1741826711430282, 22080525.
30. Bopp M, Braun J, Faeh D, Gutzwiller F. Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data. BMC Public Health 2010, 10:562. 10.1186/1471-2458-10-562, 2955001, 20858236.
31. Lloyd-Jones DM, Martin DO, Larson MG, Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998, 129(12):1020-1026.
32. Minder CE. Quality of coding of causes of death in Switzerland. Soz Praventivmed 1984, 29(6):248-250. 10.1007/BF02078258, 6516584.
33. Nishimura R, Nakagami T, Sone H, Ohashi Y, Tajima N. Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial. Cardiovasc Diabetol 2011, 10:58. 10.1186/1475-2840-10-58, 3150244, 21714932.